AAAAAA
Results: 26-36/36
Authors:
Dierlamm, J
Wlodarska, I
Michaux, L
Stefanova, M
Seeger, D
Hinz, K
Hagemeijer, A
Hossfeld, DK
Citation: J. Dierlamm et al., Fluorescence in situ hybridization (FISH): A powerful method for the detection of genetic abnormalities in metaphases and in interphase nuclei, INFUSIONSTH, 26(3), 1999, pp. 146-150
Authors:
Zhang, W
Knieling, G
Vohwinkel, G
Martinez, T
Kuse, R
Hossfeld, DK
Duhrsen, U
Citation: W. Zhang et al., Origin of stroma cells in long-term bone marrow cultures from patients with acute myeloid leukemia, ANN HEMATOL, 78(7), 1999, pp. 305-314
Authors:
Rummel, MJ
Chow, KU
Jager, E
Hossfeld, DK
Bergmann, L
Peters, HD
Hansmann, ML
Meyer, A
Hoelzer, D
Mitrou, PS
Citation: Mj. Rummel et al., Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse, ANN ONCOL, 10(1), 1999, pp. 115-117
Authors:
Wolf, G
Hegewisch-Becker, S
Hossfeld, DK
Stahl, RAK
Citation: G. Wolf et al., Hyperuricemia and renal insufficiency associated with malignant disease: Urate oxidase as an efficient therapy?, AM J KIDNEY, 34(5), 1999, pp. E201-E206
Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR
Authors:
Graeven, U
Fiedler, W
Karpinski, S
Ergun, S
Kilic, N
Rodeck, U
Schmiegel, W
Hossfeld, DK
Citation: U. Graeven et al., Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR, J CANC RES, 125(11), 1999, pp. 621-629
Authors:
Dierlamm, J
Michaux, L
Stefanova, M
Eggert, J
Leberecht, P
Seeger, D
Westerhausen, M
Hossfeld, DK
Citation: J. Dierlamm et al., Novel Philadelphia variant t(Y;9;22)(q12;q34;q11) in a case of chronic myeloid leukemia, CANC GENET, 114(2), 1999, pp. 150-153
Authors:
Dierlamm, J
Stefanova, M
Michaux, L
Lincke, E
Leberecht, P
Hossfeld, DK
Citation: J. Dierlamm et al., Unusual clinical course and acquisition of del(11)(q23) in second lymphatic blastic phase of a Ph-positive chronic myeloid leukemia, CANC GENET, 113(1), 1999, pp. 85-89
Authors:
Hehlmann, R
Hochhaus, A
Kolb, HJ
Hasford, J
Gratwohl, A
Heimpel, H
Siegert, W
Finke, J
Ehninger, G
Holler, E
Berger, U
Pfirrmann, M
Muth, A
Zander, A
Fauser, AA
Heyll, A
Nerl, C
Hossfeld, DK
Loffler, H
Pralle, H
Queisser, W
Tobler, A
Citation: R. Hehlmann et al., Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure, BLOOD, 94(11), 1999, pp. 3668-3677
Authors:
Dierlamm, J
Baens, M
Wlodarska, I
Stefanova-Ouzounova, M
Hernandez, JM
Hossfeld, DK
De Wolf-Peeters, C
Hagemeijer, A
Van den Berghe, H
Marynen, P
Citation: J. Dierlamm et al., The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas, BLOOD, 93(11), 1999, pp. 3601-3609
Authors:
Weh, HJ
Zschaber, R
Braumann, D
Hoelzer, P
Hoffmann, R
Becker, K
Kleeberg, UR
Pompecki, R
Hoffknecht, M
Benner, A
Hossfeld, DK
Citation: Hj. Weh et al., A randomized phase III study comparing weekly folinic acid (FA) and high-dose 5-fluorouracil (5-FU) with monthly 5-FU/FA (days 1-5) in untreated patients with metastatic colorectal carcinoma, ONKOLOGIE, 21(5), 1998, pp. 403-407
Authors:
Bokemeyer, C
Harstrick, A
Beyer, J
Metzner, B
Ruther, U
Hartmann, JT
Holstein, K
Derig, HG
De Wit, R
Casper, J
Schoffski, P
Kuhrer, I
Illiger, HJ
Kempf, B
Reichle, A
Foller, A
Hossfeld, DK
Fischer, JT
Berdel, WE
Gerhartz, HH
Kirchner, H
Pfluger, KH
Ostermann, H
Kanz, L
Schmoll, HJ
Citation: C. Bokemeyer et al., The use of intensive chemotherapy for non-seminomatous testicular germ cell tumors, EUROCANCER 98, 1998, pp. 321-323